Osaka University
Also known as: Chair of Ophthalmology, Osaka University Medical School | Department of breast and endocrine surgery graduate school of Medicine Osaka University | Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine | Department of Cardiovascular Medicine, Faculty of Internal Medicine, Graduate School of Osaka University, Japan | Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine | Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University | Department of Comprehensive Kidney Disease Research, Osaka University Graduate School of Medicine | Department of Dermatology, Graduate School of Medicine, Osaka University | Department of Geriatric Medicine, Osaka University Graduate School of Medicine | Department of Inter-Organ Communication Research in Kidney Disease, Osaka University Graduate School of Medicine | Department of Nephrology, Osaka University | Department of ORL, Osaka University, School of Medicine | Emeritus Professor Osaka University | Graduate School of Pharmaceutical Sciences, Osaka University | Norio Nonomura | Osaka University | Osaka University Graduate School of Medicine | Osaka University Hospital | The Research Foundation for Microbial Diseases of Osaka University | Urology, Osaka University Hospital | Yoshiharu Tsubakihara
Highest phase reached
Phase 4
First clinical trial
Apr 1, 1998Last known activity
Sep 30, 2025
Timeline
1860s
- Jan 1, 1869
Osaka University— Founded
Drugs by trial phase (243 distinct, 198 trials)
Phase 4 (76 own, 0 via acquisition)
Phase 3 (38 own, 0 via acquisition)
Phase 2 (85 own, 0 via acquisition)
- ibritumomab tiuxetan
- afatinib
- aminolevulinic acid
- atezolizumab
- asfotase alfa
- azilsartan
- bifidobacterium animalis
- candesartan
- temsirolimus
- cnt-01
- dabrafenib
- dendritic cells - transfected with htert-, survivin- and tumor cell derived mrna + ex vivo t cell expansion and reinfusion
- dextran
- doxorubicin
- dsp-7888
- +70 more
Phase 1 (19 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Acute Pain
- Albuminuria
- Altitude Sickness
- Alzheimer Disease
- Anemia
- Aneurysm
- Angina Pectoris
- Angiofibroma
- Anterior Wall Myocardial Infarction
- Aortic Aneurysm
- Aortic Aneurysm, Abdominal
- Aortic Diseases
- Aortic Valve Insufficiency
- Arthritis
- Atherosclerosis
- Autism Spectrum Disorder
- Autistic Disorder
- Back Pain
- Bacterial Infections
- Biliary Tract Neoplasms
- Bone Diseases
- Bone Diseases, Metabolic
- Brain Diseases
- Brain Injuries
- Breast Neoplasms
- Bronchiolitis
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Cardiovascular Diseases
- Celiac Disease
- Cerebral Palsy
- Chest Pain
- Child Development Disorders, Pervasive
- Chlamydia Infections
- Cholangitis
- Colitis, Ulcerative
- Colonic Neoplasms
- Colorectal Neoplasms
- Common Variable Immunodeficiency
- Communicable Diseases
- Congenital Abnormalities
- Constipation
- Contracture
- Coronary Artery Disease
- Coronary Disease
- Coronavirus Infections
- Crohn Disease
- Deficiency Diseases
- Delirium
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diphtheria
- Drug Resistant Epilepsy
- Dupuytren Contracture
- Encephalitis
- Encephalomyelitis
- Endocardial Cushion Defects
- Enterovirus Infections
- Epilepsy
- Essential Hypertension
- Familial Hypophosphatemic Rickets
- Fatigue
- Fatigue Syndrome, Chronic
- Gastroesophageal Reflux
- Gingivitis
- Glioblastoma
- Glucose Intolerance
- Graft vs Host Disease
- Head and Neck Neoplasms
- Heart Defects, Congenital
- Heart Failure
- Heart Failure, Systolic
- Heart Septal Defects
- Heart Septal Defects, Ventricular
- Hemophilia A
- Hemorrhage
- HIV Infections
- Hyperalgesia
- Hypercholesterolemia
- Hyperlipidemias
- Hyperlipoproteinemias
- Hyperphosphatemia
- Hypertension
- Hypertension, Pulmonary
- Hypophosphatasia
- Hypoxia
- Hypoxia, Brain
- Hypoxia-Ischemia, Brain
- Immunologic Deficiency Syndromes
- Infant, Newborn, Diseases
- Infarction
- Infections
Recent trials (50)
- NCT07192211OfficialPhase 2Sep 30, 2025
- NCT06441994Lead sponsorPhase 1May 24, 2024
- NCT06441994Sponsor investigatorPhase 1May 24, 2024
- NCT05442151Lead sponsorN/AMay 9, 2022
- NCT05442151Sponsor investigatorN/AMay 9, 2022
- NCT04522986Overall official - principal investigatorPhase 1Sep 30, 2020
- NCT04747002Reponsible party - principal investigatorPhase 2Jun 12, 2020
- NCT04747002Lead sponsorPhase 2Jun 12, 2020
- NCT04413344CollaboratorPhase 1/Phase 2Jun 5, 2020
- NCT04696328Study directorPhase 1Dec 2, 2019
- NCT04696328Reponsible party - principal investigatorPhase 1Dec 2, 2019
- NCT04696328Lead sponsorPhase 1Dec 2, 2019
- NCT04695522Lead sponsorPhase 1Nov 27, 2019
- NCT04695522Reponsible party - principal investigatorPhase 1Nov 27, 2019
- NCT04695522Overall official - principal investigatorPhase 1Nov 27, 2019
Details
- Founded
- Suita, Osaka, JP Jan 1, 1869
- Last known activity
- Sep 30, 2025